Ophthalmology Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Ophthalmology Market Size Analysis and Top Companies

The global ophthalmology market size is estimated to hit around USD 134.74 billion by 2033, increasing from USD 72.80 billion in 2023 with a CAGR of 6.4% from 2023 to 2033. The top companies operating in the ophthalmology are Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Essilor International S.A., Haag-Streit AG, Johnson & Johnson Vision Care, Inc., NIDEK CO., LTD., Novartis AG, STAAR Surgical Company, Topcon Corporation, Ziemer Ophthalmic Systems AG, Hoya Corporation, Lumenis Ltd., Optovue, Inc. (A Subsidiary of Carl Zeiss Meditec AG), Iridex Corporation, and Others.

Market Report Coverage

Ophthalmology Key Players

• Alcon, Inc.
• Bausch Health Companies Inc.
• Carl Zeiss Meditec AG
• Essilor International S.A.
• Haag-Streit AG
• Johnson & Johnson Vision Care, Inc.
• NIDEK CO., LTD.
• Novartis AG
• STAAR Surgical Company
• Topcon Corporation
• Ziemer Ophthalmic Systems AG
• Hoya Corporation
• Lumenis Ltd.
• Optovue, Inc. (A Subsidiary of Carl Zeiss Meditec AG)
• Iridex Corporation

Recent Developments

• In 2022, Regeneron Pharmaceuticals, Inc. received a positive development as the U.S. FDA accepted the Priority Review for the supplemental Biologics License Application (sBLA) of EYLEA (aflibercept) Injection. This acceptance, aimed at treating Retinopathy of Prematurity (ROP) in preterm infants, contributes to enhancing Regeneron's brand image in the competitive ophthalmology market.
• In 2022, Reichert, Inc. introduced its revamped refractometers and analytical instruments website, promising a significantly enhanced user experience. The redesign reflects the company's commitment to providing users with an improved interface and accessibility when exploring its range of refractometry and analytical solutions.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344